unknown
Stage
1
Investors
About
Medherant develops transdermal drug-delivery patches using a proprietary drug-in-adhesive platform (including ionic-liquid-enabled formulations) to enable sustained topical delivery of small-molecule drugs.
Explore Medherant Limited's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.